SequelSEC

Q/C TECHNOLOGIES, INC. QCLS

In Vitro & In Vivo Diagnostic Substances · CIK 0001321834 · Fiscal year ends 1231

Revenue
$1.58M
Fiscal year ended 2019-12-31
Operating income
-$3.47M
Fiscal year ended 2019-12-31
Free cash flow
Unavailable
Fiscal year ended 2019-12-31

Q/C TECHNOLOGIES, INC. (QCLS) reported revenue of $1.58M and net income of -$3.89M for the fiscal year ended 2019-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Q/C TECHNOLOGIES, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under In Vitro & In Vivo Diagnostic Substances.

Income

Q/C TECHNOLOGIES, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$1.58M$1.67M$3.35M$2.96M$2.12M$4.43M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$3.47M-$10.06M-$6.61M-$3.33M-$9.68M-$3.20M
Net income-$3.89M-$10.85M-$7.37M-$3.30M-$9.31M-$3.14M
Research & development$276.79K$1.06M$1.26M$1.19M$1.41M$916.31K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income-$3.38M-$10.85M-$7.37M-$3.30M-$9.58M-$3.13M
Income tax expenseUnavailableUnavailableUnavailableUnavailable-$269.34KUnavailable
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$3.40M$7.45M$6.13M$4.99M$6.57M$5.09M
General & administrative$3.37M$5.67M$4.08M$3.01M$4.03M$3.78M
Selling & marketing$25.00K$1.78M$2.05M$1.98M$2.54M$1.30M

Balance

Q/C TECHNOLOGIES, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Cash & equivalents$517.44K$181.76K$438.43K$72.70K$402.06K$455.84K
Total assets$10.88M$7.81M$9.34M$5.09M$8.27M$16.65M
Current assets$10.31M$6.67M$7.78M$3.19M$6.48M$13.06M
Total liabilities$1.53M$1.97M$1.79M$1.70M$1.67M$1.84M
Current liabilities$1.53M$1.97M$1.79M$1.70M$1.67M$1.84M
Total equity incl. NCI-$2.33M$5.83M$7.55M$3.39M$6.60M$14.81M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$198.98K$585.27K$947.61K$2.04M$1.13M$905.12K
Accounts receivable$42.88K$176.33K$964.67K$601.27K$609.20K$1.15M
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$891.88K$1.97M$1.79M$1.46M$1.67M$1.54M

Cash flow

Q/C TECHNOLOGIES, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating cash flow-$3.07M-$8.50M-$5.08M-$4.17MUnavailableUnavailable
Capital expendituresUnavailable$68.21K$54.51K$123.30K$112.95K$24.99K
Investing cash flow-$3.94M-$359.68K-$5.01M$3.84MUnavailableUnavailable
Financing cash flow$6.97M$9.11M$10.46MUnavailableUnavailableUnavailable
Net change in cash-$49.22K$243.32K$365.73K-$329.36K-$53.78K$352.21K
Stock-based compensation$10.80K$12.54K$5.46K$51.65K$52.36K$549.60K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$74.06K$234.49K$249.89K$286.16K$300.00K$349.40K

Derived

Q/C TECHNOLOGIES, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Free cash flowUnavailable-$8.57M-$5.13M-$4.30MUnavailableUnavailable
Gross marginUnavailable7.6%28.3%63.4%55.0%73.5%
Operating marginUnavailable-604.0%-197.1%-112.4%-457.8%-72.4%
FCF marginUnavailable-514.6%-153.1%-145.1%UnavailableUnavailable
SBC / revenueUnavailable0.8%0.2%1.7%2.5%Unavailable
Current ratio6.74x3.38xUnavailable1.88x3.88x7.08x
Revenue YoY growth-5.3%-50.4%13.3%40.0%-52.2%Unavailable
Net marginUnavailable-651.4%-219.6%-111.6%-440.3%-71.0%
R&D / revenueUnavailable63.8%37.6%40.2%66.5%20.7%
CapEx / revenueUnavailable4.1%1.6%4.2%5.3%0.6%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open QCLS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

7 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2019-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2018-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2017-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2016-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2015-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2014-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

balance equationreview2019-12-31

Difference 11688000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.